Searchable abstracts of presentations at key conferences in endocrinology

ea0044ep25 | (1) | SFEBES2016

Association of neurofibromatosis type 1 with primary hyperparathyroidism: report of a case

Austin Emily , Bates Andrew

Introduction: Neurofibromatosis Type 1 (NF1) is an autosomal dominant inherited disorder, which increases the risk of developing both benign and malignant tumours. A Swedish study conducted by Zöller et al in 1997, suggested that up to 25% of these tumours are neuroendocrine in origin, of which phaeochromocytomas were the commonest with a prevalence of 0.1–6%. The association between NF1 and primary hyperparathyroidism is described in the literature but clinically ra...

ea0049ep1259 | Thyroid (non-cancer) | ECE2017

The role of an ultra-sensitive fourth-generation TSH assay in the management of subclinical hyperthyroidism

Austin Emily , Peacey Steve , Bates Andrew

: The management of endogenous subclinical hyperthyroidism is largely guided by perceived risk, including the presence of cardiovascular disease, atrial fibrillation or osteoporosis. We have utilised a fourth-generation TSH assay, providing a 10-fold increase in sensitivity compared to third-generation assays, to determine whether patients with subclinical hyperthyroidism can be differentiated from those with overt hyperthyroidism, based on their now measurable TSH levels. Two...

ea0048cb12 | Additional Cases | SFEEU2017

Investigating menstrual disturbance: a series of unfortunate events

Vamvakopoulos Joannis , Bates Andrew , Rahim Asad

A 20-year-old lady presented to her GP with menstrual irregularity and worsening right-sided headaches with associated vomiting. Blood tests showed a mildly raised testosterone level and a markedly raised prolactin level, approximately 80% of which was macroprolactin (normal monomeric prolactin level). She was subsequently referred by her GP for an MRI Pituitary, which was reported as showing a 6-mm hypoenhancing lesion. Medical history includes migraines and hayfever; she was...

ea0041gp3 | Adrenal | ECE2016

Follow-up of adrenal incidentalomas – are we overdoing it? Follow-up of 145 patients from a single centre

Austin Emily , Miller Ben , Shepherd Lisa , Bates Andrew

Background: Current practice of monitoring adrenal incidentalomas with biochemical follow-up and repeat imaging studies is under review by the ESE.Following an audit presented in 2015, we proposed that this extensive follow-up was unnecessary in radiologically benign lesions, as neither functional nor malignant lesions were present in this subgroup.Methods: A retrospective review of the same cohort of 145 patients with adrenal inci...

ea0038p49 | Clinical practice/governance and case reports | SFEBES2015

Outcome of patients with adrenal incidentalomas: an analysis of 145 patients from a single centre

Austin Emily , Rahim Asad , Shepherd Lisa , Bates Andrew

Adrenal incidentalomas are a common clinical dilemma with increasing utilisation of cross-sectional imaging modalities. The aims of management include: i) exclusion of possible malignancy and ii) identification of hormonally active lesions.Our unit has adopted AACE guidelines, including a screen for adrenal androgen hypersecretion. This audit aimed to review the utility of such an approach.We identified case notes of 145 consecutiv...

ea0038p68 | Clinical practice/governance and case reports | SFEBES2015

Management of thyroid disease in pregnancy: experience from an antenatal thyroid clinic

Thomas Micha , Hassan-Smith Zaki , Bates Andrew , Rahim Asad

Background: Thyroid disease in pregnancy is common with hypothyroidism predominating.Objectives: To determine the aetiology of thyroid disease in patients attending an antenatal thyroid clinic, their baseline biochemical and therapeutic characteristics as well as subsequent management.Subjects/setting: 114 women with a mean 31 years (±5) age were seen by a consultant endocrinologist in the antenatal thyroid clinic, between Sep...

ea0037ep61 | Adrenal cortex | ECE2015

The utility of current guidelines in the assessment of adrenal incidentalomas

Austin Emily , Shepherd Lisa , Rahim Asad , Bates Andrew

Adrenal incidentaloma’s are a common clinical dilemma with increasing utilisation of cross-sectional imaging modalities. The aims of management include i) exclusion of possible malignancy and ii) identification of hormonally active lesions. Our unit has adopted AACE guidelines, including a screen for adrenal androgen hypersecretion. This audit aimed to review the utility of such an approach. We identified case notes of 100 consecutive adrenal incidentaloma’s referred...

ea0034p98 | Clinical practice/governance and case reports | SFEBES2014

Outcomes following pituitary surgery: a single centre audit

Manolopoulos Konstantinos , Bates Andrew S , Shad Amjad , Rahim Assad

Introduction: Pituitary surgery is associated with post-operative complications including hypopituitarism and visual field defects. In order to ensure that our surgical outcomes were comparable with other centres, we audited the outcome of a cohort of patients referred for surgery at a single centre.Methods: A retrospective audit of 27 consecutive patients diagnosed with pituitary adenoma at Heartlands Hospital Birmingham, who underwent trans-sphenoidal ...

ea0034p198 | Nursing practise | SFEBES2014

Emergency hydrocortisone kits: assessment of knowledge and skills of patients and family

Shepherd Lisa , Ulnasah Sadaf , Rahim Asad , Shakher Jayadave , Bates Andrew

It is recommended that patients with adrenal insufficiency should be in possession of an emergency hydrocortisone kit and have sufficient knowledge and skills to administer it. Historically, in our unit patient education was dependent on referral from Doctors to endocrine specialist nurses (ESN’s). This study sought to assess if patients owned a kit and if patients and family were competent to administer the injection if required.A ‘snapshot&#1...

ea0028p4 | Bone | SFEBES2012

The impact of different vitamin D preparations for the treatment of vitamin D deficiency in primary hyperparathyroidism (PTHP)

Ludlam Sophie , Richardson Thomas , Kakad Rakhi , Bates Andrew , Rahim Asad

We have previously demonstrated that 80% of patients with PTHP will have co-existing vitamin D deficiency suggesting an increased metabolism of vitamin D. There are few data assessing the impact and safety of different vitamin D preparations on calcium, parathyroid hormone (PTH) and vitamin D in this group. Here, we report the details of replacement therapy using different vitamin D preparations. In a retrospective study of 22 (20F:2M and 8 Asian:14 Non-Asian) patients with co...